-
1
-
-
84929359985
-
WHO classification of tumours of haematopoietic and lymphoid tissues
-
4th edition. Edited by Hasserjian RP, Gattermann N, Bennett JM, Brunning RD, Thiele J. Lyon: IARC
-
Swerdlow SH, Campo E, Harris NE, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW: WHO classification of tumours of haematopoietic and lymphoid tissues. In Refractory Anaemia with Ring Sideroblasts. 4th edition. Edited by Hasserjian RP, Gattermann N, Bennett JM, Brunning RD, Thiele J. Lyon: IARC; 2008:96-97.
-
(2008)
Refractory Anaemia with Ring Sideroblasts
, pp. 96-97
-
-
Swerdlow, S.H.1
Campo, E.2
Harris, N.E.3
Jaffe, E.S.4
Pileri, S.A.5
Stein, H.6
Thiele, J.7
Vardiman, J.W.8
-
2
-
-
33749325187
-
Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation
-
Szpurka H, Tiu R, Murugesan G, Aboudola S, Hsi ED, Theil KS, Sekeres MA, Maciejewski JP: Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation. Blood 2006, 108:2173-2181.
-
(2006)
Blood
, vol.108
, pp. 2173-2181
-
-
Szpurka, H.1
Tiu, R.2
Murugesan, G.3
Aboudola, S.4
Hsi, E.D.5
Theil, K.S.6
Sekeres, M.A.7
Maciejewski, J.P.8
-
3
-
-
33750299561
-
The JAK2 V617F mutation is rare in RARS but common in RARS-T
-
Ceesay MM, Lea NC, Ingram W, Westwood NB, Gaken J, Mohamedali A, Cervera J, Germing U, Gattermann N, Giagounidis A, Garcia-Casado Z, Sanz G, Mufti GJ: The JAK2 V617F mutation is rare in RARS but common in RARS-T. Leukemia 2006, 20:2060-2061.
-
(2006)
Leukemia
, vol.20
, pp. 2060-2061
-
-
Ceesay, M.M.1
Lea, N.C.2
Ingram, W.3
Westwood, N.B.4
Gaken, J.5
Mohamedali, A.6
Cervera, J.7
Germing, U.8
Gattermann, N.9
Giagounidis, A.10
Garcia-Casado, Z.11
Sanz, G.12
Mufti, G.J.13
-
4
-
-
77949732119
-
Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis
-
Flach J, Dicker F, Schnittger S, Kohlmann A, Haferlach T, Haferlach C: Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis. Haematologica 2010, 95:518-519.
-
(2010)
Haematologica
, vol.95
, pp. 518-519
-
-
Flach, J.1
Dicker, F.2
Schnittger, S.3
Kohlmann, A.4
Haferlach, T.5
Haferlach, C.6
-
5
-
-
67249103795
-
The role of JAK2 mutations in RARS and other MDS
-
Hellstrom-Lindberg E, Cazzola M: The role of JAK2 mutations in RARS and other MDS. Hematol Am Soc Hematol Educ Program 2008, 2008:52-59. doi:10.1182/asheducation-2008.1.52ASH Education Book.
-
(2008)
Hematol Am Soc Hematol Educ Program
, vol.2008
, pp. 52-59
-
-
Hellstrom-Lindberg, E.1
Cazzola, M.2
-
6
-
-
44849143798
-
The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts
-
Boultwood J, Pellagatti A, Nikpour M, Pushkaran B, Fidler C, Cattan H, Littlewood TJ, Malcovati L, Della Porta MG, Jädersten M, Killick S, Giagounidis A, Bowen D, Hellström-Lindberg E, Cazzola M, Wainscoat JS: The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. PLoS One 2008, 3:e1970.
-
(2008)
PLoS One
, vol.3
, pp. e1970
-
-
Boultwood, J.1
Pellagatti, A.2
Nikpour, M.3
Pushkaran, B.4
Fidler, C.5
Cattan, H.6
Littlewood, T.J.7
Malcovati, L.8
Della Porta, M.G.9
Jädersten, M.10
Killick, S.11
Giagounidis, A.12
Bowen, D.13
Hellström-Lindberg, E.14
Cazzola, M.15
Wainscoat, J.S.16
-
7
-
-
33745615399
-
Gene expression profiles of CD34+ cells in myelodysplastic syndromes: Involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype
-
Pellagatti A, Cazzola M, Giagounidis AA, Malcovati L, Porta MG, Killick S, Campbell LJ, Wang L, Langford CF, Fidler C, Oscier D, Aul C, Wainscoat JS, Boultwood J: Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. Blood 2006, 108:337-345.
-
(2006)
Blood
, vol.108
, pp. 337-345
-
-
Pellagatti, A.1
Cazzola, M.2
Giagounidis, A.A.3
Malcovati, L.4
Porta, M.G.5
Killick, S.6
Campbell, L.J.7
Wang, L.8
Langford, C.F.9
Fidler, C.10
Oscier, D.11
Aul, C.12
Wainscoat, J.S.13
Boultwood, J.14
-
8
-
-
80053900941
-
Frequent pathway mutations of splicing machinery in myelodysplasia
-
Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M, Chalkidis G, Suzuki Y, Shiosaka M, Kawahata R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Ishiyama K, Mori H, Nolte F, Hofmann WK, Miyawaki S, Sugano S, Haferlach C, Koeffler HP, Shih LY, Haferlach T, Chiba S, Nakauchi H, et al: Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011, 478:64-69.
-
(2011)
Nature
, vol.478
, pp. 64-69
-
-
Yoshida, K.1
Sanada, M.2
Shiraishi, Y.3
Nowak, D.4
Nagata, Y.5
Yamamoto, R.6
Sato, Y.7
Sato-Otsubo, A.8
Kon, A.9
Nagasaki, M.10
Chalkidis, G.11
Suzuki, Y.12
Shiosaka, M.13
Kawahata, R.14
Yamaguchi, T.15
Otsu, M.16
Obara, N.17
Sakata-Yanagimoto, M.18
Ishiyama, K.19
Mori, H.20
Nolte, F.21
Hofmann, W.K.22
Miyawaki, S.23
Sugano, S.24
Haferlach, C.25
Koeffler, H.P.26
Shih, L.Y.27
Haferlach, T.28
Chiba, S.29
Nakauchi, H.30
more..
-
9
-
-
80054010617
-
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts
-
Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, Pellagatti A, Wainscoat JS, Hellstrom-Lindberg E, Gambacorti-Passerini C, Godfrey AL, Rapado I, Cvejic A, Rance R, McGee C, Ellis P, Mudie LJ, Stephens PJ, McLaren S, Massie CE, Tarpey PS, Varela I, Nik-Zainal S, Davies HR, Shlien A, Jones D, Raine K, Hinton J, Butler AP, Teague JW: Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011, 365:1384-1395.
-
(2011)
N Engl J Med
, vol.365
, pp. 1384-1395
-
-
Papaemmanuil, E.1
Cazzola, M.2
Boultwood, J.3
Malcovati, L.4
Vyas, P.5
Bowen, D.6
Pellagatti, A.7
Wainscoat, J.S.8
Hellstrom-Lindberg, E.9
Gambacorti-Passerini, C.10
Godfrey, A.L.11
Rapado, I.12
Cvejic, A.13
Rance, R.14
McGee, C.15
Ellis, P.16
Mudie, L.J.17
Stephens, P.J.18
McLaren, S.19
Massie, C.E.20
Tarpey, P.S.21
Varela, I.22
Nik-Zainal, S.23
Davies, H.R.24
Shlien, A.25
Jones, D.26
Raine, K.27
Hinton, J.28
Butler, A.P.29
Teague, J.W.30
more..
-
10
-
-
84857994411
-
SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
-
Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A, O'Keefe C, Rogers HJ, Sekeres MA, Maciejewski JP, Tiu RV: SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia 2012, 26:542-545.
-
(2012)
Leukemia
, vol.26
, pp. 542-545
-
-
Visconte, V.1
Makishima, H.2
Jankowska, A.3
Szpurka, H.4
Traina, F.5
Jerez, A.6
O'Keefe, C.7
Rogers, H.J.8
Sekeres, M.A.9
Maciejewski, J.P.10
Tiu, R.V.11
-
11
-
-
84883637783
-
SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype
-
Visconte V, Tabarroki A, Rogers HJ, Hasrouni E, Traina F, Makishima H, Hamilton BK, Liu Y, O'Keefe C, Lichtin A, Horwitz L, Sekeres MA, Hsieh FH, Tiu RV: SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype. Haematologica 2013, 98:e105-107.
-
(2013)
Haematologica
, vol.98
, pp. e105-e107
-
-
Visconte, V.1
Tabarroki, A.2
Rogers, H.J.3
Hasrouni, E.4
Traina, F.5
Makishima, H.6
Hamilton, B.K.7
Liu, Y.8
O'Keefe, C.9
Lichtin, A.10
Horwitz, L.11
Sekeres, M.A.12
Hsieh, F.H.13
Tiu, R.V.14
-
12
-
-
84859597590
-
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
-
Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A, Przychodzen B, Bupathi M, Guinta K, Afable MG, Sekeres MA, Padgett RA, Tiu RV, Maciejewski JP: Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 2012, 119:3203-3210.
-
(2012)
Blood
, vol.119
, pp. 3203-3210
-
-
Makishima, H.1
Visconte, V.2
Sakaguchi, H.3
Jankowska, A.M.4
Abu Kar, S.5
Jerez, A.6
Przychodzen, B.7
Bupathi, M.8
Guinta, K.9
Afable, M.G.10
Sekeres, M.A.11
Padgett, R.A.12
Tiu, R.V.13
Maciejewski, J.P.14
-
13
-
-
84863481799
-
Defects in spliceosomal machinery: A new pathway of leukaemogenesis
-
Maciejewski JP, Padgett RA: Defects in spliceosomal machinery: a new pathway of leukaemogenesis. Br J Haematol 2012, 158:165-173.
-
(2012)
Br J Haematol
, vol.158
, pp. 165-173
-
-
Maciejewski, J.P.1
Padgett, R.A.2
-
14
-
-
84871236747
-
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders
-
Visconte V, Makishima H, Maciejewski JP, Tiu RV: Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders. Leukemia 2012, 26:2447-54.
-
(2012)
Leukemia
, vol.26
, pp. 2447-2454
-
-
Visconte, V.1
Makishima, H.2
Maciejewski, J.P.3
Tiu, R.V.4
-
15
-
-
84868091622
-
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes
-
Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F, McMahon J, Makishima H, Szpurka H, Jankowska A, Jerez A, Sekeres MA, Saunthararajah Y, Advani AS, Copelan E, Koseki H, Isono K, Padgett RA, Osman S, Koide K, O'Keefe C, Maciejewski JP, Tiu RV: SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. Blood 2012, 120:3173-3186.
-
(2012)
Blood
, vol.120
, pp. 3173-3186
-
-
Visconte, V.1
Rogers, H.J.2
Singh, J.3
Barnard, J.4
Bupathi, M.5
Traina, F.6
McMahon, J.7
Makishima, H.8
Szpurka, H.9
Jankowska, A.10
Jerez, A.11
Sekeres, M.A.12
Saunthararajah, Y.13
Advani, A.S.14
Copelan, E.15
Koseki, H.16
Isono, K.17
Padgett, R.A.18
Osman, S.19
Koide, K.20
O'Keefe, C.21
Maciejewski, J.P.22
Tiu, R.V.23
more..
-
16
-
-
14644431836
-
Mammalian polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1
-
Isono K, Mizutani-Koseki Y, Komori T, Schmidt-Zachmann MS, Koseki H: Mammalian polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1. Genes Dev 2005, 19:536-541.
-
(2005)
Genes Dev
, vol.19
, pp. 536-541
-
-
Isono, K.1
Mizutani-Koseki, Y.2
Komori, T.3
Schmidt-Zachmann, M.S.4
Koseki, H.5
-
18
-
-
84855370035
-
SF3B1 and other novel cancer genes in chronic lymphocytic leukemia
-
Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K, Werner L, Sivachenko A, De Luca DS, Zhang L, Zhang W, Vartanov AR, Fernandes SM, Goldstein NR, Folco EG, Cibulskis K, Tesar B, Sievers QL, Shefler E, Gabriel S, Hacohen N, Reed R, Meyerson M, Golub TR, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ: SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011, 365:2497-2506.
-
(2011)
N Engl J Med
, vol.365
, pp. 2497-2506
-
-
Wang, L.1
Lawrence, M.S.2
Wan, Y.3
Stojanov, P.4
Sougnez, C.5
Stevenson, K.6
Werner, L.7
Sivachenko, A.8
De Luca, D.S.9
Zhang, L.10
Zhang, W.11
Vartanov, A.R.12
Fernandes, S.M.13
Goldstein, N.R.14
Folco, E.G.15
Cibulskis, K.16
Tesar, B.17
Sievers, Q.L.18
Shefler, E.19
Gabriel, S.20
Hacohen, N.21
Reed, R.22
Meyerson, M.23
Golub, T.R.24
Lander, E.S.25
Neuberg, D.26
Brown, J.R.27
Getz, G.28
Wu, C.J.29
more..
-
19
-
-
84929305172
-
SF3B1 mutant clones from patients with refractory anaemia with ringed sideroblasts (RARS) originate from the early haematopoietic stem cells and maintain their engraftment potential
-
Mian SA, Rouault-Pierre K, Smith AS, Seidl T, Kulasekararaj AG, Mohamedali AM, Shinde S, Bonnet D, Mufti GJ: SF3B1 mutant clones from patients with refractory anaemia with ringed sideroblasts (RARS) originate from the early haematopoietic stem cells and maintain their engraftment potential. Blood (ASH Annual Meeting) 2013, 122:262.
-
(2013)
Blood (ASH Annual Meeting)
, vol.122
, pp. 262
-
-
Mian, S.A.1
Rouault-Pierre, K.2
Smith, A.S.3
Seidl, T.4
Kulasekararaj, A.G.5
Mohamedali, A.M.6
Shinde, S.7
Bonnet, D.8
Mufti, G.J.9
-
20
-
-
79953093440
-
Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice
-
Ramirez-Herrick AM, Mullican SE, Sheehan AM, Conneely OM: Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice. Blood 2011, 117:2681-90.
-
(2011)
Blood
, vol.117
, pp. 2681-2690
-
-
Ramirez-Herrick, A.M.1
Mullican, S.E.2
Sheehan, A.M.3
Conneely, O.M.4
-
21
-
-
79958744030
-
Mouse models of myelodysplastic syndromes
-
Wegrzyn J, Lam JC, Karsan A: Mouse models of myelodysplastic syndromes. Leuk Res 2011, 35:853-62.
-
(2011)
Leuk Res
, vol.35
, pp. 853-862
-
-
Wegrzyn, J.1
Lam, J.C.2
Karsan, A.3
-
22
-
-
84908299112
-
Haploinsufficiency of Sf3b1 leads to compromised stem cell function but not to myelodysplasia
-
Matsunawa M, Yamamoto R, Sanada M, Sato-Otsubo A, Shiozawa Y, Yoshida K, Otsu M, Shiraishi Y, Miyano S, Isono K, Koseki H, Nakauchi H, Ogawa S: Haploinsufficiency of Sf3b1 leads to compromised stem cell function but not to myelodysplasia. Leukemia 2014, 28:1844. doi:10.1038/leu.2014.73.
-
(2014)
Leukemia
, vol.28
, pp. 1844
-
-
Matsunawa, M.1
Yamamoto, R.2
Sanada, M.3
Sato-Otsubo, A.4
Shiozawa, Y.5
Yoshida, K.6
Otsu, M.7
Shiraishi, Y.8
Miyano, S.9
Isono, K.10
Koseki, H.11
Nakauchi, H.12
Ogawa, S.13
-
23
-
-
55749114037
-
Characteristics of US patients with myelodysplastic syndromes: Results of six cross-sectional physician surveys
-
Sekeres MA, Schoonen WM, Kantarjian H, List A, Fryzek J, Paquette R, Maciejewski JP: Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys. J Natl Cancer Inst 2008, 100:1542-51.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 1542-1551
-
-
Sekeres, M.A.1
Schoonen, W.M.2
Kantarjian, H.3
List, A.4
Fryzek, J.5
Paquette, R.6
Maciejewski, J.P.7
-
24
-
-
84904392234
-
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome
-
Chen TC, Hou HA, Chou WC, Tang JL, Kuo YY, Chen CY, Tseng MH, Huang CF, Lai YJ, Chiang YC, Lee FY, Liu MC, Liu CW, Liu CY, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF: Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome. Blood Cancer Journal 2014, 4:e177.
-
(2014)
Blood Cancer Journal
, vol.4
, pp. e177
-
-
Chen, T.C.1
Hou, H.A.2
Chou, W.C.3
Tang, J.L.4
Kuo, Y.Y.5
Chen, C.Y.6
Tseng, M.H.7
Huang, C.F.8
Lai, Y.J.9
Chiang, Y.C.10
Lee, F.Y.11
Liu, M.C.12
Liu, C.W.13
Liu, C.Y.14
Yao, M.15
Huang, S.Y.16
Ko, B.S.17
Hsu, S.C.18
Wu, S.J.19
Tsay, W.20
Chen, Y.C.21
Tien, H.F.22
more..
-
25
-
-
84897019526
-
Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice
-
Wang J, Li Z, He Y, Pan F, Chen S, Rhodes S, Nguyen L, Yuan J, Jiang L, Yang X, Weeks O, Liu Z, Zhou J, Ni H, Cai CL, Xu M, Yang FC: Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice. Blood 2014, 123:541-53.
-
(2014)
Blood
, vol.123
, pp. 541-553
-
-
Wang, J.1
Li, Z.2
He, Y.3
Pan, F.4
Chen, S.5
Rhodes, S.6
Nguyen, L.7
Yuan, J.8
Jiang, L.9
Yang, X.10
Weeks, O.11
Liu, Z.12
Zhou, J.13
Ni, H.14
Cai, C.L.15
Xu, M.16
Yang, F.C.17
-
26
-
-
43249103972
-
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
-
Watanabe-Okochi N, Kitaura J, Ono R, Harada H, Harada Y, Komeno Y, Nakajima H, Nosaka T, Inaba T, Kitamura T: AML1 mutations induced MDS and MDS/AML in a mouse BMT model. Blood 2008, 111:4297-308.
-
(2008)
Blood
, vol.111
, pp. 4297-4308
-
-
Watanabe-Okochi, N.1
Kitaura, J.2
Ono, R.3
Harada, H.4
Harada, Y.5
Komeno, Y.6
Nakajima, H.7
Nosaka, T.8
Inaba, T.9
Kitamura, T.10
-
27
-
-
77953176036
-
A scaling normalization method for differential expression analysis of RNA-seq data
-
Robinson MD, Oshlack A: A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 2010, 11:R25.
-
(2010)
Genome Biol
, vol.11
, pp. R25
-
-
Robinson, M.D.1
Oshlack, A.2
-
28
-
-
84896735766
-
Voom: Precision weights unlock linear model analysis tools for RNA-seq read counts
-
Law CW, Chen Y, Shi W, Smyth GK: Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol 2014, 15:R29.
-
(2014)
Genome Biol
, vol.15
, pp. R29
-
-
Law, C.W.1
Chen, Y.2
Shi, W.3
Smyth, G.K.4
-
29
-
-
0001677717
-
Controlling the false discovery rate: A practical and powerful approach to multiple testing
-
Benjamini Y H Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statis Soc B 1995, 57:289-300.
-
(1995)
J R Statis Soc B
, vol.57
, pp. 289-300
-
-
Benjamini, Y.H.Y.1
-
30
-
-
84866911829
-
Camera: A competitive gene set test accounting for inter-gene correlation
-
Wu D, Smyth GK: Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res 2012, 40:e133.
-
(2012)
Nucleic Acids Res
, vol.40
, pp. e133
-
-
Wu, D.1
Smyth, G.K.2
-
31
-
-
79958135926
-
Molecular signatures database (MSigDB) 3.0
-
Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP: Molecular signatures database (MSigDB) 3.0. Bioinformatics 2011, 27:1739-1740.
-
(2011)
Bioinformatics
, vol.27
, pp. 1739-1740
-
-
Liberzon, A.1
Subramanian, A.2
Pinchback, R.3
Thorvaldsdottir, H.4
Tamayo, P.5
Mesirov, J.P.6
|